GeminIQ Website Logo

Viewing ILMN free

Start free trial

Subscribe for full history, 50+ metrics, screener, watchlist...

ILLUMINA, INC.

ILMN

Companies in Laboratory Analytical Instruments

AMTDWATRVTYBIOBRKR

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
1,0891,4181,0509341,1131,1278699201,1081,0489271,553
Short Term Investments
66215228221124937074-666
Accounts Receivable Net Current
738854729701699735699641635734690741
Inventory Net
611564590575537547574561584587615617
Prepaid Expense And Other Assets Current
234238199210200244161263256234268306
Assets Current
2,7383,2892,7962,6412,6732,7462,3732,4592,5832,6092,5063,223
Property Plant And Equipment Net
7557597487647828158328599641,0071,0401,069
Operating Lease Right Of Use Asset
371370382397410419453460550544581638
Goodwill
1,2841,1131,1131,1131,1131,1131,1131,0792,5452,5452,5273,239
Intangible Assets Net Excluding Goodwill
4302102252382782953052782,9402,9933,0293,188
Deferred Income Tax Assets Net
458454490534553567617632-56--
Other Assets Noncurrent
523449423400373348321314458357439417
Assets
6,5596,6446,1776,0876,1826,3036,0146,08110,04010,11110,12211,774
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
218240218200207221191199201245240244
Accrued Liabilities Current
8498467467627348277841,2651,2731,3251,2421,309
Notes Payable Current
499499998499499499-744-000
Convertible Debt Current
---------00750
Liabilities Current
1,5661,5851,9621,4611,4401,5479752,2081,4741,5701,4822,303
Operating Lease Liability Noncurrent
475486506528539554613616700687698726
Long Term Notes Payable
1,4901,4909941,4921,4911,4901,9881,4901,4901,4891,4891,488
Other Liabilities Noncurrent
352360334348344339313331642620555702
Stockholders Equity Inclu…
Preferred Stock Value
-0---0---0--
Stockholders Equity
Common Stock Value
222222222222
Additional Paid In Capital
7,8627,8227,7627,6767,6087,5257,4497,3479,6589,5559,4879,397
Accumulated Other Comprehensive Income Loss Net Of…
1-10-12-21822-51412-12112
Retained Earnings Accumulated Deficit
-258-392-726-876-1,111-1,242-1,428-2,133-145-19157911
Treasury Stock Common Value
-4,931-4,699-4,645-4,523-4,139-3,934-3,893-3,794-3,793-3,792-3,769-3,767
Stockholders Equity
2,6762,7232,3812,2582,3682,3732,1251,4365,7345,7455,8986,555
Liabilities And Stockholders Equity
6,5596,6446,1776,0876,1826,3036,0146,08110,04010,11110,12211,774
Preferred Stock Par Or Stated Value Per Share
-0.01---0.01---0.01--
Preferred Stock Shares Authorized
-10---10---10--
Preferred Stock Shares Issued
-0---0---0--
Preferred Stock Shares Outstanding
-0---0---0--
Common Stock Par Or Stated Value Per Share
-0.01---0.01---0.01--
Common Stock Shares Authorized
-320---320---320--
Common Stock Shares Issued
-201---200---199--
Shares Outstanding
-153---159---159--
Treasury Stock Common Shares
-48---41---40--

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202616.93%26.68%39.26%---------
20258.55%25.12%44.27%7.54%8.55%0.85%0.25%9.10%14.66%8.90%11.31%18.65%
2024-9.71%-7.94%-0.20%8.51%7.45%17.22%-5.06%-10.91%-10.28%-16.37%-28.40%-24.80%
2023-1.89%1.01%-4.59%-9.00%-25.84%-41.00%21.72%40.62%55.42%-5.56%-10.92%-17.77%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.75
2.08
1.43
1.81
1.86
1.78
2.43
1.11
1.75
1.66
1.69
1.40
Quick Ratio
1.21
1.57
1.02
1.27
1.34
1.26
1.68
0.74
1.18
1.14
1.10
1.00
Working Capital
1.17B
1.70B
834.00M
1.18B
1.23B
1.20B
1.40B
251.00M
1.11B
1.04B
1.02B
920.00M
Leverage & Debt
Debt to Equity
0.59
0.58
0.82
0.65
0.61
0.65
0.46
1.54
0.26
0.27
0.25
0.35
Interest Coverage TTM
8.52
7.99
7.71
11.54
-5.21
-8.33
-12.58
-35.07
-14.88
-13.88
-15.65
-74.26
Debt Ratio
0.24
0.24
0.32
0.24
0.23
0.25
0.16
0.36
0.15
0.16
0.15
0.20
Efficiency & Turnover
Asset Turnover TTM
0.69
0.67
0.70
0.70
0.53
0.53
0.54
0.50
0.41
0.40
0.42
0.33
Days Sales Outstanding TTM
59.70
66.77
60.78
57.17
56.13
61.32
57.74
56.95
52.80
56.93
53.86
56.57
Receivables Turnover TTM
6.11
5.47
6.01
6.38
6.50
5.95
6.32
6.41
6.91
6.41
6.78
6.45
Per Share Metrics
Diluted EPS TTM
5.54
5.45
4.56
8.01
-6.08
-7.69
-9.91
-19.14
-8.11
-7.35
-7.11
-26.49
Free Cash Flow Per Share TTM
6.37
6.01
6.54
6.57
5.51
4.46
3.44
2.25
2.30
1.79
1.07
-0.27
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
66.20%
66.08%
66.21%
66.55%
66.34%
65.44%
63.92%
61.98%
61.34%
60.92%
61.44%
62.24%
Operating Profit Margin TTM
19.39%
18.58%
18.17%
30.18%
-12.87%
-19.05%
-26.65%
-60.17%
-24.84%
-23.73%
-23.13%
-88.21%
Net Profit Margin TTM
19.42%
19.57%
16.37%
29.34%
-22.27%
-27.97%
-36.10%
-68.73%
-28.71%
-25.78%
-25.17%
-93.81%
Growth Metrics
Net Revenue Growth (1Y)
1.29%
-0.66%
-2.32%
-3.27%
-3.47%
-2.93%
-1.70%
-0.74%
1.01%
-1.75%
-4.96%
-4.90%
Net Income Growth (1Y)
-188.30%
-169.50%
-144.29%
-141.29%
-25.12%
5.34%
41.01%
-27.28%
-71.25%
-73.64%
-72.93%
21,931.58%
EPS Growth (1Y)
-191.77%
-171.29%
-146.03%
-141.82%
-25.12%
4.68%
40.13%
-27.74%
-71.43%
-73.80%
-73.10%
21,792.14%
Valuation Metrics
P/E TTM
22.11
23.92
20.70
11.92
-13.06
-17.37
-13.08
-5.45
-16.46
-18.43
-18.77
-6.88
P/B TTM
7.05
7.47
6.10
6.63
5.33
8.95
9.76
11.56
3.70
3.73
3.58
4.40
P/S TTM
4.29
4.68
3.39
3.50
2.91
4.86
4.72
3.75
4.73
4.75
4.72
6.46
Market Cap
18.86B
20.33B
14.53B
14.98B
12.62B
21.25B
20.74B
16.60B
21.24B
21.40B
21.10B
28.82B
Enterprise Value
19.76B
20.90B
15.47B
16.04B
13.49B
22.11B
21.85B
17.91B
21.62B
21.84B
21.66B
29.50B
Calculated Values
Free Cash Flow TTM
974.00M
931.00M
1.00B
1.03B
876.00M
709.00M
547.00M
357.00M
366.00M
283.00M
169.00M
-43.00M
Net Debt
900.00M
571.00M
942.00M
1.06B
877.00M
862.00M
1.12B
1.31B
382.00M
441.00M
562.00M
685.00M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-25Sale
Owner: Davies, Scott M
Title: Chief Legal Officer
Shares: 615
Price/Share: $180.00
Value: $110,700.00
Shares Owned: 20,953
Relationship: Officer
Ownership: Direct
2026-06-05Sale
Owner: Leckman, Patricia
Title: SVP, Chief People Officer
Shares: 783
Price/Share: $164.13
Value: $128,513.79
Shares Owned: 21,259
Relationship: Officer
Ownership: Direct
2026-06-02Sale
Owner: Leckman, Patricia
Title: SVP, Chief People Officer
Shares: 784
Price/Share: $161.89
Value: $126,921.76
Shares Owned: 22,042
Relationship: Officer
Ownership: Direct
2026-06-01Sale
Owner: Meister, Keith A.
Title: -
Shares: 235,000
Price/Share: $163.95
Value: $38,528,250.00
Shares Owned: 2,830,452
Relationship: Director
Ownership: Indirect
2026-05-29Sale
Owner: Davies, Scott M
Title: Chief Legal Officer
Shares: 615
Price/Share: $160.00
Value: $98,400.00
Shares Owned: 21,568
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart
2026-03-31
98.59%
Inst. Shares: 150,842,437
Shares Outstanding: 153,000,000
2025-12-31
98.98%
Inst. Shares: 153,417,868
Shares Outstanding: 155,000,000
2025-09-30
99.70%
Inst. Shares: 152,542,725
Shares Outstanding: 153,000,000
2025-06-30
95.64%
Inst. Shares: 150,157,851
Shares Outstanding: 157,000,000
2025-03-31
92.13%
Inst. Shares: 146,491,898
Shares Outstanding: 159,000,000

ILLUMINA, INC. (ILMN) — SEC Financial Statements & Analysis

ILLUMINA, INC. (ILMN) is a laboratory analytical instruments company, incorporated in DE. ILLUMINA, INC. trades on ILMN: Nasdaq as: ILMN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ILLUMINA, INC. reported a 1.29% year-over-year revenue growth, a Gross Profit Margin of 66.20% (TTM), a Debt-to-Equity ratio of 0.59x, a Price-to-Sales (P/S) ratio of 4.29x (TTM), a Price-to-Book (P/B) ratio of 7.05 (TTM), at a market cap of $18.86B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
1.29%
Gross Profit Margin TTM
66.20%
Debt To Equity
0.59x
P/S TTM
4.29x
P/B TTM
7.05
Market Cap
$18.86B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ILLUMINA, INC. in?

ILLUMINA, INC. (ILMN) operates in the Laboratory Analytical Instruments industry.

What is ILMN's market cap?

ILLUMINA, INC. (ILMN) has a market capitalization of $18.86B as of 2026-03-31.

What is ILMN's P/E ratio?

ILLUMINA, INC. (ILMN)'s trailing twelve month P/E ratio is 22.11x as of 2026-03-31.

What exchange does ILMN trade on?

ILLUMINA, INC. (ILMN) trades on the ILMN: Nasdaq.

Where is ILLUMINA, INC. incorporated?

ILLUMINA, INC. is incorporated in DE.

GeminIQ Research & Analysis

July 9, 2026Stock Buybacks vs. Stock Compensation: Running in PlaceA ranked leaderboard of the companies where stock-based compensation issuance offset the entire share-count benefit of a multi-billion-dollar buyback program, built from ten years of as-filed SEC 10-K data via GeminIQ.

Research Faster.
Invest Smarter.

Start 7-day free trial

ILLUMINA, INC. (ILMN) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.